Avalo Therapeutics, Inc. (AVTX) stock
AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.13−0.24 (-3.26%)
Close on Nov 17, 2026Market cap $382.38MP/E –Yield –
Avalo Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Avalo Therapeutics's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $32.83M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $13.49M | -58.9% |
| FY2021 | Dec 31, 2021 | $32.83M | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $15.38M | – |
| FY2017 | Dec 31, 2017 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $2.35M | -57.7% |
| FY2015 | Dec 31, 2015 | $5.56M | -22.9% |
| FY2014 | Dec 31, 2014 | $7.21M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $10.47M | -68.1% |
| Q4 FY2022 | Dec 31, 2022 | $13.49M | – |
| Q3 FY2022 | Sep 30, 2022 | $16.50M | +7.8% |
| Q2 FY2022 | Jun 30, 2022 | $18.71M | +22.1% |
| Q4 FY2021 | Dec 31, 2021 | $32.83M | +113.8% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $15.30M | -0.6% |
| Q2 FY2019 | Jun 30, 2019 | $15.33M | -0.6% |
| Q1 FY2019 | Mar 31, 2019 | $15.35M | -0.2% |
| Q4 FY2018 | Dec 31, 2018 | $15.38M | – |
| Q3 FY2018 | Sep 30, 2018 | $15.40M | – |
| Q2 FY2018 | Jun 30, 2018 | $15.43M | +1169.5% |
| Q1 FY2018 | Mar 31, 2018 | $15.38M | +415.2% |
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $0 | -100.0% |
| Q2 FY2017 | Jun 30, 2017 | $1.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.35M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.19M | – |
See a number that looks wrong?